Gregory W. Fulton ALS and Neuromuscular Disease Center

09/08/2025

Attention bookworms: Our "BE FAST" bookmarks are back! We've once again partnered with Maricopa County Library District to help our community recognize the signs of a stroke.

Check out a library book from any Maricopa County Library District branch, and you'll receive a Barrow bookmark explaining the signs of a in both English and Spanish—while supplies last!

Remember to "BE FAST," and you could help save a life. Learn more at BarrowNeuro.org/Stroke.

09/05/2025

The Franke Education Center is funding multiple positions at for 2026!

This opportunity is available to and trainees, and attending neurosurgeons and neurologists who have completed residency within the past five years. To be eligible for this funding, candidates must be training or working in a low- or middle-income country.

This funding covers roundtrip airfare and lodging for up to three months of neurological or neurosurgical observation at Barrow in , .

We are accepting applications for this funding through Oct. 31, 2025. Learn more and apply at https://bar.rw/observers.

09/04/2025

Dilan Ellegala, MD, co-director of , has been selected as a distinguished speaker by University Hospitals Research & Education Institute in Cleveland, Ohio.

The 2025-26 Distinguished Speaker Series is a free, monthly webinar series featuring nationally and internationally renowned experts invited to share their perspectives on health services research, population health, and . It is open to the public.

📆: Tuesday, Nov. 4, 2025
⏰: 11 a.m. to Noon (EST)/ 9 to 10 a.m. (MST/Arizona time)
📍: Virtual

To learn more and to sign up for Dr. Ellegala's webinar, please visit https://bar.rw/speakerseries.

09/02/2025

Have you been diagnosed with (MCI)? You could help advance our understanding of healthy brain aging by joining a research study. Learn more: https://bar.rw/tread

08/29/2025

Congratulations to professor Fredric Manfredsson, PhD, and his collaborators at Binghamton University in New York on receiving a research grant from The Michael J. Fox Foundation for Parkinson's Research to study the biological mechanisms underlying anxiety as a symptom of .

The researchers aim to determine whether accumulation of the alpha-synuclein protein in the brain disrupts function of the amygdala, the brain's emotional processing center, leading to . They will investigate this using a novel preclinical model from Dr. Manfredsson’s lab, which overexpresses human .

Learn more in the story by Parkinson's News Today at https://bar.rw/mjff-anxiety.

08/29/2025

08/28/2025

Join the data revolution, and sign up for an ALL ALS study today!

Researchers gain a deeper understanding of each person’s unique ALS experience by studying and sharing data from thousands of people impacted by ALS. This knowledge is essential for the discovery of better therapeutic targets and the development of new treatments for ALS.

By contributing your biofluid samples (blood and optional cerebrospinal fluid) and engaging in health outcome activities, you can play a vital role in advancing .

Visit the https://ALL-ALS.org, or contact Info@ALL-ALS.org, to learn about in-person or remote participation.

08/27/2025

Marwan Sabbagh, MD, FAAN, the Vice Chair of Research in the Department of and the Moreno Family Chair for at , was featured in an article by Healio for a presentation he recently gave on blarcamesine research.

According to the abstract presented by Dr. Sabbagh at the Alzheimer's Association International Conference, a daily dose of blarcamesine restored autophagy among patients with early , with improved outcomes through 192 weeks.

Researchers are starting to take a closer look at autophagy, which is the body's cellular recycling system, in the context of disease. Dr. Sabbagh said the idea that amyloid accumulation is the earliest seminal event in triggering the progression of Alzheimer’s is now being reconceptualized.

Read the article at https://bar.rw/blarcamesine to learn more.

08/27/2025

“I literally went from being in excruciating pain to having zero pain post-surgery.”

Nicholas Aretakis is back to living the active life he loves after having minimally invasive with Juan Uribe, MD. Originally offered a more invasive procedure, Dr. Uribe saw an opportunity to harness advanced operative technology available at , along with his decades of experience, to give Nicholas a shortened recovery time reduced risk of complications.

Now, Nicholas is back on the golf course and back to walking 3-5 miles per day.

Learn more at https://bar.rw/3UNp0fL.

08/26/2025

Earlier this month, we welcomed our first neurology observer funded by the Franke Education Center. The Franke family is funding two positions at this year.

Dr. Yodit Molla (left) is visiting Barrow for three months from Addis Ababa, Ethiopa, where she completed a residency and now works at ALERT Comprehensive Specialized Hospital.

Dr. Molla said she discovered the Barrow observership on social media and applied in hopes of learning from one of the world's leading neurological institutes, particularly in care, and exploring how she could adapt the practices at Barrow to her own country.

"Stroke care in Ethiopia has a long way to go, but I believe progress happens one step a time," she added.

Here, Dr. Molla is pictured with Huiam Mubarak, MD, the director of Barrow . Learn more at BarrowNeuro.org/Global.

08/25/2025

is recruiting adults living with (ALS) and their caregivers for a comprehensive survey assessing the needs and perspectives of the community.

To sign up, please reach out to Fulton.Research@CommonSpirit.org or visit https://redcap.link/alsneedsbarrow.

08/22/2025

Nicki Niemann, MD, a movement disorders in the at , was honored by the local chapter of the Huntington's Disease Society of America (HDSA) at its recent “Celebration of Hope” community fundraising event.

Each year, the event recognizes honorees in different categories, such as professionals and community members. These honorees are acknowledged for going above and beyond to improve the lives of people with in some way.

Dr. Niemann leads the Huntington’s disease program at Barrow, which is the only HDSA Center of Excellence in . As such, Barrow serves an important role in providing specialty treatment and clinical trial participation for people with Huntington’s in the state.

Learn more at BarrowNeuro.org/MAPC.